An organic chemist by training, Dr Nuria Oliva specialised in biomaterials and nanotechnology for medical applications during her PhD at the Massachusetts Institute of Technology (MIT) in the US. In 2018, she joined the Almquist lab at Imperial College London as a postdoctoral fellow to work on nanotechnology-enabled therapies to promote healing of non-union fractures and chronic wounds.

In September 2020, Nuria became an Imperial College Research Fellow in the Department of Bioengineering, where her group is studying novel nanotechnology and biomaterial approaches to tackle complex human diseases like chronic wounds, osteoarthritis and cancer. Nuria was awarded the 2019 Young Investigator Award from the European Tissue Repair Society and was highly commended in the 2020 Aviva Women of the Future awards in the Science category.

Here Nuria discusses a recently published, British Skin Foundation-funded paper describing a nanotechnology-based therapy to heal chronic wounds.

DOWNLOAD THE PDF TO READ THE FULL ARTICLE